One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Journals package 3months
-
http://medilib.ir
- Duration of Time : 93 Day
Price : 100$- Special Price : 50$
Circulation Editors and Editorial Board.
doi : 10.1161/CIR.0000000000001407
Volume 153(1) pgs. 1-67,e1-e3 January 06, 2026
Conceptual Models to Explain Heart Failure With a Preserved Ejection Fraction: A Tale of Futility, Frustration, and Perhaps, Fruition.
Cardiac Allograft Vasculopathy Inhibition With Alirocumab: The CAVIAR Trial.
When the Target Is Not the Driver: Rethinking LDL in Cardiac Allograft Vasculopathy.
Randomized Controlled Trial of Mechanical Thrombectomy With Anticoagulation Versus Anticoagulation Alone for Acute Intermediate-High Risk Pulmonary Embolism: Primary Outcomes From the STORM-PE Trial.
Deep Learning-Based Continuous QT Monitoring to Identify High-Risk Prolongation Events After Class III Antiarrhythmic Initiation.
N-Palmitoyl Glutamine Is a Candidate Mediator of Cardiorespiratory Fitness.
Dapagliflozin Reduces Epicardial Adipose Tissue and Myocardial Fibrosis in Subclinical Heart Failure: The DAPA-EAT Trial.
Letter by Huang et al Regarding Article, "Electronic Provider Notification to Facilitate the Recognition and Management of Severe Aortic Stenosis: A Randomized Clinical Trial".
Response by Tanguturi and Elmariah to Letter Regarding Article, "Electronic Provider Notification to Facilitate the Recognition and Management of Severe Aortic Stenosis: A Randomized Clinical Trial".
